Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | CASP1 | P29466 | 2/20 | 0.46 |
| ▸ | CASP7 | P55210 | 2/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | HBB | P68871 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | GLA | P06280 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 6/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | NQO2 | P16083 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8218109 | 1.00 | ALDH1A1 (0.46) | ALDH1A1HSD17B10CYP3A4TDP1CASP1 | |
| SCHEMBL8905235 | 1.00 | ALDH1A1 (0.46) | ALDH1A1HSD17B10CYP3A4TDP1CASP1 | |
| SCHEMBL440327 | 0.97 | ALDH1A1 (0.42) | ALDH1A1HSD17B10CYP3A4TDP1CASP1 | |
| SCHEMBL240787 | 0.81 | — | — | |
| SCHEMBL51694 | 0.81 | — | — | |
| Benz(B)Anthracene SCHEMBL7947 | 0.80 | ALDH1A1 (0.61) | ALDH1A1HSD17B10CYP3A4TDP1CASP1 | |
| SCHEMBL22634171 | 0.80 | ALDH1A1 (0.61) | ALDH1A1HSD17B10CYP3A4TDP1CASP1 | |
| Benz(B)Anthracene SCHEMBL22352910 | 0.80 | ALDH1A1 (0.61) | ALDH1A1HSD17B10CYP3A4TDP1CASP1 | |
| Benz(B)Anthracene SCHEMBL3474922 | 0.80 | ALDH1A1 (0.61) | ALDH1A1HSD17B10CYP3A4TDP1CASP1 | |
| SCHEMBL25181 | 0.80 | ALDH1A1 (0.61) | ALDH1A1HSD17B10CYP3A4TDP1CASP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11183340-B2 | Method for manufacturing solid electrolytic capacitor | SHOWA DENKO K.K. (JP) | 2021-11-23 | — | — | US | disclosed |
| US-11136432-B2 | Method for producing polyisothianaphthene-based electroconductive polymer | SHOWA DENKO K.K. (JP) | 2021-10-05 | — | — | US | disclosed |
| US-20200090874-A1 | METHOD FOR MANUFACTURING SOLID ELECTROLYTIC CAPACITOR | SHOWA DENKO K.K. (JP) | 2020-03-19 | — | — | US | disclosed |
| US-20190345287-A1 | METHOD FOR PRODUCING POLYISOTHIANAPHTHENE-BASED ELECTROCONDUCTIVE POLYMER | SHOWA DENKO K.K. (JP) | 2019-11-14 | — | — | US | disclosed |
| US-20190337919-A1 | FUSED HETEROPOLYCYCLIC COMPOUND, AND METHOD FOR PRODUCING CONDUCTIVE POLYMER IN WHICH SAID COMPOUND IS USED | SHOWA DENKO K.K. (JP) | 2019-11-07 | — | — | US | disclosed |
| EP-3564290-A1 | METHOD FOR PRODUCING POLYISOTHIANAPHTHENE ELECTROCONDUCTIVE POLYMER | Showa Denko K.K. (JP) | 2019-11-06 | — | — | EP | disclosed |
| EP-3564229-A1 | FUSED HETEROPOLYCYCLIC COMPOUND, AND METHOD FOR PRODUCING CONDUCTIVE POLYMER IN WHICH SAID COMPOUND IS USED | Showa Denko K.K. (JP) | 2019-11-06 | — | — | EP | disclosed |
| EP-3564976-A1 | METHOD FOR MANUFACTURING SOLID ELECTROLYTIC CAPACITOR | Showa Denko K.K. (JP) | 2019-11-06 | — | — | EP | disclosed |
| US-5688873-A | POLYISOBENZOTHIOPHENE, POLYISOBENZOFURAN, POLYISOINDOLE AND RELATED POLYMERS, AROMATIC RESINS, SULFONATE GROUP, WATER SOLUBILITY | SHOWA DENKO K.K. (JP) | 1997-11-18 | — | — | US | disclosed |
| US-5648453-A | Electroconductive polymer and process for producing the polymer | SHOWA DENKO K.K. (JP) | 1997-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190337919-A1 | FUSED HETEROPOLYCYCLIC COMPOUND, AND METHOD FOR PRODUCING CONDUCTIVE POLYMER IN WHICH SAID COMPOUND IS USED | SCO2, SQOR, GJB2 | ALDH1A1 2352/4885HSD17B10 1649/4885CYP3A4 1156/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.